Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-08-21 Purchase |
2020-08-24 4:31 pm |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
30,000 | $0.69 | $20,700 | 53,251 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-06-30 Option Award |
2021-07-02 4:10 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
3,391 | $1.9465 | 91,115 (Direct) |
View |
| 2021-05-01 Option Award |
2021-05-04 4:39 pm |
N/A 2031-05-01 |
VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle CHIEF COMMERCIAL OFFICER |
300,000 | $0 | 300,000 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $1.5 | 66,609 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-27 4:13 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0 | 66,609 (Direct) |
View |
| 2021-04-23 Option Award |
2021-04-27 4:10 pm |
N/A 2031-04-23 |
VistaGen Therapeutics Inc. | VTGN | Curley Joanne Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:06 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
2,500 | $1.5 | 2,500 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:06 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
2,500 | $0 | 2,500 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:03 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
2,500 | $1.5 | 55,751 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 7:03 pm |
2018-08-29 2021-04-26 |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
2,500 | $0 | 55,751 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-02 5:17 pm |
N/A 2031-02-01 |
VistaGen Therapeutics Inc. | VTGN | Ginski Mark J SENIOR VP, HEAD OF CMC |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-02-02 5:16 pm |
N/A 2030-09-09 |
VistaGen Therapeutics Inc. | VTGN | Ginski Mark J SENIOR VP, HEAD OF CMC |
0 | $0 | 50,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:59 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Cunningham Ann Michelle Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:58 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
300,000 | $0 | 361,609 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:58 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Singh Shawn CHIEF EXECUTIVE OFFICER |
5,000 | $0.4521 | 361,609 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:57 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
150,000 | $0 | 160,000 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:57 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | DOTSON JERROLD DUANE VP, CFO AND SECRETARY |
5,000 | $0.4521 | 160,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:55 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
150,000 | $0 | 160,000 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:55 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | Smith Mark Alan CHIEF MEDICAL OFFICER |
5,000 | $0.4521 | 160,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:54 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | SAXE JON S Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:52 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | Underdown Brian J. Director |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:51 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | MCPARTLAND MARK A. VP CORPORATE DEVELOPMENT |
150,000 | $0 | 150,000 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:48 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
150,000 | $0 | 237,724 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-04 4:48 pm |
N/A N/A |
VistaGen Therapeutics Inc. | VTGN | SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER |
5,000 | $0.4521 | 237,724 (Direct) |
View |
| 2020-12-30 Option Award |
2021-01-04 4:47 pm |
N/A 2030-12-30 |
VistaGen Therapeutics Inc. | VTGN | GIN JERRY B Director |
75,000 | $0 | 75,000 (Direct) |
View |